Genovis: Strategic investment in developer of RNase inhibitors
Research Note
2024-07-04
16:34
Redeye comments on Genovis following the announcement of a strategic investment in SEQURNA, a developer of next-generation RNase inhibitors. Similar to the market, we positively view the announcement.
FE
Filip Einarsson
Disclosures and disclaimers